Spinal muscular atrophy in the neonate
- PMID: 14971549
- DOI: 10.1177/0884217503261125
Spinal muscular atrophy in the neonate
Abstract
Spinal muscular atrophy (SMA) type I is an autosomal recessive disorder characterized by loss of lower motor neurons in the spinal cord. This severe hereditary neurodegenerative disorder is an important cause of morbidity in the neonate and the leading hereditary cause of infant mortality. The characteristic degeneration of anterior horn cells in the spinal cord leads to progressive muscular weakness and atrophy of the skeletal muscles. In SMA type I, the most severe form of SMA, death usually ensues by 2 years of age from respiratory failure or infection. Accurate diagnosis is now available through genetic testing, and progress is being made toward the development of therapy based on understanding of the disease mechanism. The neonatal nurse plays a pivotal role in identifying and caring for these medically fragile infants and in providing support and education for parents and families.
Similar articles
-
Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.Neurology. 2005 Nov 22;65(10):1631-5. doi: 10.1212/01.wnl.0000184506.61354.5b. Neurology. 2005. PMID: 16301493
-
Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.Genet Test. 2008 Mar;12(1):53-6. doi: 10.1089/gte.2007.0030. Genet Test. 2008. PMID: 18298318
-
Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.Ann Hum Genet. 2005 Mar;69(Pt 2):216-21. doi: 10.1046/j.1529-8817.2004.00149.x. Ann Hum Genet. 2005. PMID: 15720302
-
Spinal muscular atrophy.Semin Pediatr Neurol. 2002 Jun;9(2):145-50. doi: 10.1053/spen.2002.33801. Semin Pediatr Neurol. 2002. PMID: 12138998 Review.
-
Therapeutics development for spinal muscular atrophy.NeuroRx. 2006 Apr;3(2):235-45. doi: 10.1016/j.nurx.2006.01.010. NeuroRx. 2006. PMID: 16554261 Free PMC article. Review.
Cited by
-
A schematic approach to hypotonia in infancy.Paediatr Child Health. 2005 Sep;10(7):397-400. doi: 10.1093/pch/10.7.397. Paediatr Child Health. 2005. PMID: 19668647 Free PMC article.
-
Solution structure of the core SMN-Gemin2 complex.Biochem J. 2012 Aug 1;445(3):361-70. doi: 10.1042/BJ20120241. Biochem J. 2012. PMID: 22607171 Free PMC article.
-
Risdiplam for the Use of Spinal Muscular Atrophy.Orthop Rev (Pavia). 2021 Jul 12;13(2):25579. doi: 10.52965/001c.25579. eCollection 2021. Orthop Rev (Pavia). 2021. PMID: 34745484 Free PMC article. Review.
-
Zinc-finger proteins in health and disease.Cell Death Discov. 2017 Nov 13;3:17071. doi: 10.1038/cddiscovery.2017.71. eCollection 2017. Cell Death Discov. 2017. PMID: 29152378 Free PMC article. Review.
-
Emerging treatment options for spinal muscular atrophy.Curr Treat Options Neurol. 2009 Mar;11(2):90-101. doi: 10.1007/s11940-009-0012-x. Curr Treat Options Neurol. 2009. PMID: 19210911
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical